GSK’s head of finance in China is banned from leaving the countryBMJ 2013; 347 doi: https://doi.org/10.1136/bmj.f4691 (Published 23 July 2013) Cite this as: BMJ 2013;347:f4691
- Jane Parry
- 1Hong Kong
UK national Steve Nechelput, the head of finance for GlaxoSmithKline’s China operations, has been barred from leaving the country since the end of June as investigations into widespread bribery by GSK executives continue.
A GSK spokesperson said, “We have been aware of the travel restrictions on Steve since the end of June. At no point has he been questioned, arrested or detained. He …
Log in using your username and password
Log in through your institution
Sign up for a free trial